[Indications for corticotherapy in endocrine and metabolic pathology].
作者信息
Baquet R
出版信息
Maroc Med. 1969 Aug-Sep;49(527):522-3.
PMID:5398381
Abstract
摘要
相似文献
1
[Indications for corticotherapy in endocrine and metabolic pathology].
Maroc Med. 1969 Aug-Sep;49(527):522-3.
2
Discontinued drugs in 2008: endocrine and metabolic.2008 年被停用的药物：内分泌和代谢类。
Expert Opin Investig Drugs. 2009 Sep;18(9):1243-55. doi: 10.1517/13543780903132673.
3
4
Endocrine emergencies.内分泌急症
Br J Hosp Med. 1979 Jan;21(1):38-44.
5
Pharmacological chaperones: potential treatment for conformational diseases.药理伴侣分子：构象疾病的潜在治疗方法。
Trends Endocrinol Metab. 2004 Jul;15(5):222-8. doi: 10.1016/j.tem.2004.05.003.
6
[On the therapeutic use of vitamin E in clinical medicine: motivations and prospects].
Acta Vitaminol Enzymol. 1977;31(1-5):125-42.
7
[Current therapeutics 1990-1995 in the field of endocrinology-metabolism].[1990 - 1995年内分泌 - 代谢领域的当前疗法]
Rev Med Liege. 1996 Aug;51(8):503-9.
8
Discontinued drugs in 2005: endocrine and metabolic.
Expert Opin Investig Drugs. 2007 Feb;16(2):129-36. doi: 10.1517/13543784.16.2.129.
9
Endocrine emergencies. Part 1.
Med J Aust. 1980 Sep 6;2(5):244-6.
10
Unraveling the intricacies of receptor activated cell signaling and transcriptional cascades enhance opportunities to develop new therapeutic targets for endocrine and metabolic diseases.揭示受体激活的细胞信号传导和转录级联反应的复杂性，增加了开发内分泌和代谢疾病新治疗靶点的机会。
Curr Opin Pharmacol. 2010 Dec;10(6):607-12. doi: 10.1016/j.coph.2010.10.001. Epub 2010 Oct 28.
Zotero 插件